103 related articles for article (PubMed ID: 31451225)
1. Biochemical insight into pseudouridine synthase 7 (PUS7) as a novel interactor of sirtuin, SIRT1.
Dalal S; Deshmukh P; Unni S; Padavattan S; Padmanabhan B
Biochem Biophys Res Commun; 2019 Oct; 518(3):598-604. PubMed ID: 31451225
[TBL] [Abstract][Full Text] [Related]
2. The human pseudouridine synthase PUS7 recognizes RNA with an extended multi-domain binding surface.
Guegueniat J; Halabelian L; Zeng H; Dong A; Li Y; Wu H; Arrowsmith CH; Kothe U
Nucleic Acids Res; 2021 Nov; 49(20):11810-11822. PubMed ID: 34718722
[TBL] [Abstract][Full Text] [Related]
3. PUS7 promotes the proliferation of colorectal cancer cells by directly stabilizing SIRT1 to activate the Wnt/β-catenin pathway.
Zhang Q; Fei S; Zhao Y; Liu S; Wu X; Lu L; Chen W
Mol Carcinog; 2023 Feb; 62(2):160-173. PubMed ID: 36222184
[TBL] [Abstract][Full Text] [Related]
4. Pseudouridine synthase 7 impacts Candida albicans rRNA processing and morphological plasticity.
Pickerill ES; Kurtz RP; Tharp A; Guerrero Sanz P; Begum M; Bernstein DA
Yeast; 2019 Nov; 36(11):669-677. PubMed ID: 31364194
[TBL] [Abstract][Full Text] [Related]
5. Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis.
Cui Q; Yin K; Zhang X; Ye P; Chen X; Chao J; Meng H; Wei J; Roeth D; Li L; Qin Y; Sun G; Zhang M; Klein J; Huynhle M; Wang C; Zhang L; Badie B; Kalkum M; He C; Yi C; Shi Y
Nat Cancer; 2021 Sep; 2(9):932-949. PubMed ID: 35121864
[TBL] [Abstract][Full Text] [Related]
6. HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance.
Song D; Guo M; Xu S; Song X; Bai B; Li Z; Chen J; An Y; Nie Y; Wu K; Wang S; Zhao Q
J Exp Clin Cancer Res; 2021 May; 40(1):170. PubMed ID: 33990203
[TBL] [Abstract][Full Text] [Related]
7. Sirt1 interaction with active Smad2 modulates transforming growth factor-β regulated transcription.
García-Vizcaíno EM; Liarte S; Alonso-Romero JL; Nicolás FJ
Cell Commun Signal; 2017 Nov; 15(1):50. PubMed ID: 29187201
[TBL] [Abstract][Full Text] [Related]
8. Pseudouridine synthase 7 is an opportunistic enzyme that binds and modifies substrates with diverse sequences and structures.
Purchal MK; Eyler DE; Tardu M; Franco MK; Korn MM; Khan T; McNassor R; Giles R; Lev K; Sharma H; Monroe J; Mallik L; Koutmos M; Koutmou KS
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35058356
[TBL] [Abstract][Full Text] [Related]
9. PUS7: a targetable epitranscriptomic regulator of glioblastoma growth.
Zhang DY; Ming GL; Song H
Trends Pharmacol Sci; 2021 Dec; 42(12):976-978. PubMed ID: 34657723
[TBL] [Abstract][Full Text] [Related]
10. Probing the mechanism of SIRT1 activation by a 1,4-dihydropyridine.
Manna D; Bhuyan R; Ghosh R
J Mol Model; 2018 Nov; 24(12):340. PubMed ID: 30448921
[TBL] [Abstract][Full Text] [Related]
11. Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors.
Therrien E; Larouche G; Nguyen N; Rahil J; Lemieux AM; Li Z; Fournel M; Yan TP; Landry AJ; Lefebvre S; Wang JJ; MacBeth K; Heise C; Nguyen A; Besterman JM; Déziel R; Wahhab A
Bioorg Med Chem Lett; 2015 Jun; 25(12):2514-8. PubMed ID: 25971769
[TBL] [Abstract][Full Text] [Related]
12. Dual role of Zn2+ in maintaining structural integrity and suppressing deacetylase activity of SIRT1.
Chen L; Feng Y; Zhou Y; Zhu W; Shen X; Chen K; Jiang H; Liu D
J Inorg Biochem; 2010 Feb; 104(2):180-5. PubMed ID: 19923004
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T
Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955
[TBL] [Abstract][Full Text] [Related]
14. SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity.
Pan M; Yuan H; Brent M; Ding EC; Marmorstein R
J Biol Chem; 2012 Jan; 287(4):2468-76. PubMed ID: 22157016
[TBL] [Abstract][Full Text] [Related]
15. The 2.5 Å crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition.
Zhao X; Allison D; Condon B; Zhang F; Gheyi T; Zhang A; Ashok S; Russell M; MacEwan I; Qian Y; Jamison JA; Luz JG
J Med Chem; 2013 Feb; 56(3):963-9. PubMed ID: 23311358
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in inhibitors of sirtuin1/2: an update and perspective.
Zhou Z; Ma T; Zhu Q; Xu Y; Zha X
Future Med Chem; 2018 Apr; 10(8):907-934. PubMed ID: 29642711
[TBL] [Abstract]
